Rebecca Johnsson - Setterwalls

Profile

I assist Swedish and international companies with advice on mergers and acquisitions (M&A), stock market law and various types of corporate law issues.

In my daily work, I assist companies with advice in connection with, in particular, IPOs, fundraisings and general corporate law matters. I also have experience in assisting Swedish and foreign clients in connection with general meetings and acquisitions.

Språk: English, Swedish, Swedish

Case

Setterwalls advises Cantargia in connection with a capital raise of approximately SEK 124 million and entering into a loan agreement

Setterwalls has advised Ascelia Pharma in connection with a private placement

Setterwalls has advised Iconovo in connection with a directed share issue and a rights issue

Setterwalls advises Alligator Bioscience in connection with a capital raise of approximately SEK 120 million and renegotiation of loan

Setterwalls advises Alligator Bioscience in connection with a rights issue of approximately SEK 280 million

Setterwalls advised Ascelia Pharma in connection with a fully subscribed rights issue of units

Setterwalls has advised EQL Pharma in connection with listing on Nasdaq Stockholm

Setterwalls advises Alligator Bioscience in connection with rights issue of approximately SEK 150 million

Setterwalls has advised Crunchfish in connection with rights issue

Setterwalls has assisted SynAct Pharma in connection with a private placement of SEK 60.5 million

Setterwalls has advised Alligator Bioscience in connection with rights issue of approximately SEK 181 million

Setterwalls has assisted SynAct Pharma in connection with the acquisition of TXP Pharma and private placement

Setterwalls has advised InCoax Networks in connection with rights issue and over-allotment

Setterwalls has advised Qlife Holding in connection with rights issue

Setterwalls has advised SynAct Pharma AB in connection with listing on Nasdaq Stockholm

Setterwalls has advised Arise AB in connection with issue of green bonds on Nasdaq Stockholm

Setterwalls has advised inriver AB in connection with a major growth investment from Thomas H. Lee Partners (THL)

Setterwalls has advised SynAct Pharma AB in connection with a fully guaranteed rights issue of approximately SEK 150 million

Setterwalls has advised Resurs Holding and Solid Försäkring in connection with the Lex Asea distribution of shares and admission to trading on Nasdaq Stockholm

Setterwalls has advised Amniotics AB (publ) in connection with listing on Nasdaq First North Growth Market

Setterwalls advises Linkfire A/S in connection with listing on Nasdaq First North Premier Growth Market

Setterwalls advises Ascelia Pharma in connection with SEK 200 million private placement

Setterwalls has advised Alligator Bioscience in connection with over-subscribed rights issue

Setterwalls has advised Curando Nordic AB in connection with a rights issue

Setterwalls advised Thunderful Group AB in connection with the listing on Nasdaq First North Premier Growth Market

Setterwalls advises Boozt in connection with cross-listing on Nasdaq Copenhagen and offering of DKK 602 million